Evidence gathered over the last two decades indicate that TGFβ signaling impairment often lead to neuroinflammation, neuronal dysfunction and neurodegenerative changes, and could be involved in the pathogenesis of neurodegenerative diseases (Tesseur and Wyss-Coray, 2006). Here, TGFB1 is linked to neurodegenerative disease.